Organization

Berlin Heals

1 clinical trial

5 abstracts

Abstract
Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Safety analyses from the randomized, placebo (PBO)-controlled, phase 3 TALAPRO-2 study.
Org: Peter MacCallum Cancer Centre, Melbourne, Australia, Melbourne, Australia, Australian Catholic University, Institut Gustave Roussy, University of Paris-Saclay,
Abstract
ASSESSMENT OF PARTICLE-ASSOCIATED REVERSE TRANSCRIPTASE IN PLASMA OF AUTOIMMUNE DISEASE PATIENTS WITH SCLERODERMA, SLE, OR SPONDYLITIS ANKYLOSANS
Org: Center for Biological Safety, Robert Koch-Institute, Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands, Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany, Berlin Heals,
Abstract
ADALIMUMAB REDUCES ACUTE INFLAMMATORY LESIONS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: MRI RESULTS OF A 52-WEEK, OPEN-LABEL TRIAL
Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Radiology and Nuclear Medicine Unit, Morgagni-Pierantoni Hospital, Forli, Italy, University Hospital Charité Campus Benjamin Franklin, Berlin Heals, Centre of Rheumatology Ruhrgebiet,
Abstract
ADALIMUMAB IS EFFECTIVE AND WELL-TOLERATED IN TREATING ANKYLOSING SPONDYLITIS (AS) IN REAL-LIFE CLINICAL PRACTICE: PRELIMINARY RESULTS OF THE RHAPSODY TRIAL
Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Charité University Hospital, Berlin Heals, Germany, CHU de Henri-Mondor,
Abstract
ADALIMUMAB (HUMIRA®) IS EFFECTIVE AND SAFE IN TREATING RHEUMATOID ARTHRITIS (RA) IN REAL-LIFE CLINICAL PRACTICE: FINAL SUMMARY OF THE 6610 PATIENTS IN THE REACT STUDY
Org: Charité University Medicine Berlin, Humboldt University of Berlin, Berlin Heals, Germany, Gregorio Marañón University General Hospital,